Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
423 East 23rd Street
New York, NY 10016Phone+1 212-686-7500Fax+1 323-226-2657
Education & Training
- NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2018
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2012 - 2015
- University of Cincinnati College of MedicineClass of 2012
Certifications & Licensure
- NY State Medical License 2015 - 2026
- CA State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma.Jun-Chieh J Tsay, Fares Darawshy, Chan Wang, Benjamin Kwok, Kendrew K Wong
Cancer Epidemiology, Biomarkers & Prevention. 2024-11-01 - 7 citationsGlutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade inmutant lung cancer.Ray Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum
Science Advances. 2024-03-29 - 1 citationsDON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism.Ray Pillai, Thales Papagiannakopoulous
Cancer Research. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: